D9750C00001: Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors (clinicaltrials.gov) - Sep 26, 2026 - P1/2 | N=392 | Recruiting | Sponsor: AstraZeneca | N=280 ➔ 392 | Trial completion date: Jul 2027 ➔ Mar 2029 | Trial primary completion date: Jul 2027 ➔ Mar 2029
Enrollment change • Trial completion date • Trial primary completion date • Esophageal Adenocarcinoma • Esophageal Cancer • Gastric Adenocarcinoma • Gastric Cancer • Gastroesophageal Cancer • Oncology • Pancreatic Cancer • Solid Tumor • CLDN18
|